TrialJournal of clinical pharmacology2025

Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM).

Stephen J Balevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.